Government Properties Income Trust (GOV) 20.46

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Government Properties Income Trust (GOV) 20.46 $GOV

Government Propertiesome Trust Has Returned 40.4% Since SmarTrend Recommendation (GOV)
Comtex SmarTrend(R) - Fri Jun 10, 12:53PM CDT
SmarTrend identified an Uptrend for Government Propertiesome Trust (NYSE:GOV) on February 26th, 2016 at $14.73. In approximately 4 months, Government Propertiesome Trust has returned 40.39% as of today's recent price of $20.68.
GOV: 20.46 (-0.20)

35.1% Return Seen to Date on SmarTrend Government Propertiesome Trust Call (GOV)
Comtex SmarTrend(R) - Fri Jun 03, 12:32AM CDT
SmarTrend identified an Uptrend for Government Propertiesome Trust (NYSE:GOV) on February 26th, 2016 at $14.73. In approximately 3 months, Government Propertiesome Trust has returned 35.10% as of today's recent price of $19.90.
GOV: 20.46 (-0.20)

Government Properties Income Trust to Present at REITWeek 2016 on June 8, 2016
BusinessWire - Thu Jun 02, 3:01PM CDT
Government Properties Income Trust (NYSE: GOV) today announced that President and Chief Operating Officer David Blackman and Chief Financial Officer Mark Kleifges will be presenting at the REITWeek 2016: NAREIT Investor Forum in New York on Wednesday, June 8, 2016 at 1:15 p.m. Eastern Time.
GOV: 20.46 (-0.20), RMR: 29.46 (-0.11)

Government Properties Income Trust Prices $300 Million of 5.875% Senior Notes Due 2046
BusinessWire - Thu May 19, 5:07PM CDT
Government Properties Income Trust (NYSE: GOV) today announced that it has priced an underwritten public offering of $300 million of 5.875% senior unsecured notes due May 1, 2046 ("Notes".
GOV: 20.46 (-0.20), RMR: 29.46 (-0.11)

Shares of GOV Up 30.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 19, 12:27AM CDT
SmarTrend identified an Uptrend for Government Propertiesome Trust (NYSE:GOV) on February 26th, 2016 at $14.73. In approximately 3 months, Government Propertiesome Trust has returned 30.48% as of today's recent price of $19.22.
GOV: 20.46 (-0.20)

Government Properties Income Trust Announces Annual Meeting Results
BusinessWire - Tue May 17, 3:01PM CDT
Government Properties Income Trust (NYSE: GOV) today announced the results of its 2016 Annual Meeting of Shareholders which was held earlier today as follows.
GOV: 20.46 (-0.20), RMR: 29.46 (-0.11)

Government Properties Income Trust reports 1Q results
Automated Insights - Thu Apr 28, 6:33AM CDT
NEWTON, Mass. (AP) _ Government Properties Income Trust (GOV) on Thursday reported a key measure of profitability in its first quarter, after reporting a loss in the same period a year earlier. The results exceeded Wall Street expectations.
GOV: 20.46 (-0.20)

Government Properties Income Trust Announces First Quarter Results
BusinessWire - Thu Apr 28, 6:00AM CDT
--Same Property Cash Basis NOI for the First Quarter Increased by 2.4% Year over Year
GOV: 20.46 (-0.20), SIR: 25.33 (-0.14), RMR: 29.46 (-0.11)

Government Propertiesome Trust Shares Up 25.5% Since SmarTrend's Buy Recommendation (GOV)
Comtex SmarTrend(R) - Tue Apr 26, 1:29PM CDT
SmarTrend identified an Uptrend for Government Propertiesome Trust (NYSE:GOV) on February 26th, 2016 at $14.73. In approximately 2 months, Government Propertiesome Trust has returned 25.46% as of today's recent price of $18.48.
GOV: 20.46 (-0.20)

26.6% Return Seen to Date on SmarTrend Government Propertiesome Trust Call (GOV)
Comtex SmarTrend(R) - Tue Apr 19, 1:02AM CDT
SmarTrend identified an Uptrend for Government Propertiesome Trust (NYSE:GOV) on February 26th, 2016 at $14.73. In approximately 2 months, Government Propertiesome Trust has returned 26.61% as of today's recent price of $18.65.
GOV: 20.46 (-0.20)

Government Properties Income Trust First Quarter 2016 Conference Call Scheduled for Thursday, April 28th
BusinessWire - Thu Apr 14, 7:00AM CDT
Government Properties Income Trust (NYSE: GOV) today announced that it will issue a press release containing its first quarter 2016 financial results before the NYSE opens on Thursday, April 28, 2016. At 11:00 a.m. Eastern Time that morning, President David Blackman and Chief Financial Officer Mark Kleifges will host a conference call to discuss these results.
GOV: 20.46 (-0.20), RMR: 29.46 (-0.11)

Government Properties Income Trust Announces Quarterly Common Dividend
BusinessWire - Wed Apr 13, 7:00AM CDT
Government Properties Income Trust (NYSE: GOV) today announced a regular quarterly common share distribution of $0.43 per common share ($1.72 per share per year). This distribution will be paid to GOV's common shareholders of record as of the close of business on April 25, 2016 and distributed on or about May 23, 2016.
GOV: 20.46 (-0.20), RMR: 29.46 (-0.11)

Government Propertiesome Trust Has Returned 21.7% Since SmarTrend Recommendation (GOV)
Comtex SmarTrend(R) - Mon Apr 11, 1:15PM CDT
SmarTrend identified an Uptrend for Government Propertiesome Trust (NYSE:GOV) on February 26th, 2016 at $14.73. In approximately 2 month, Government Propertiesome Trust has returned 21.72% as of today's recent price of $17.93.
GOV: 20.46 (-0.20)

Government Properties Income Trust Fourth Quarter Conference Call Scheduled for Thursday, February 18th
BusinessWire - Thu Feb 04, 3:01PM CST
Government Properties Income Trust (NYSE: GOV) today announced that it will issue a press release containing its fourth quarter 2015 financial results before the NYSE opens on Thursday, February 18, 2016. At 11:00 a.m. Eastern Time that morning, President David Blackman and Chief Financial Officer Mark Kleifges will host a conference call to discuss these results.
GOV: 20.46 (-0.20), RMR: 29.46 (-0.11)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Expands Wave Energy Project in Europe

Updated Category News Views 229

Eco Wave Power Initiates Key Infrastructure Enhancements Eco Wave Power Global AB (publ) (NASDAQ: WAVE) is excited to unveil plans for crucial upgrades at its groundbreaking wave energy project. This groundbreaking initiative is set to harness ocean wave energy to produce clean electricity efficiently. Eco Wave Power, recognized as a leading company in onshore wave energy...

Continue Reading
Key Managerial Transactions Reported by Danske Bank A/S

Updated Category News Views 162

Recent Mandatory Transaction Notifications by Danske Bank A/S Danske Bank A/S is committed to transparency in financial transactions involving its managerial personnel. This communication signifies the bank's adherence to the EU Market Abuse Regulation and the requirements set by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen. Understanding...

Continue Reading
Strategic Insights into Symbotic's Options Market Activity

Updated Category News Views 187

Overview of Options Activity for Symbotic Recently, significant investors have demonstrated a notably bearish outlook on Symbotic. This trend has been evidenced by the options activity surrounding the company's stock, symbolized by SYM. The strong presence of whales entering the market indicates a shift in investor sentiment, with nuances that are crucial for...

Continue Reading
South Coast AQMD Takes Action on Oil Facilities During Violations

Updated Category News Views 267

South Coast AQMD Addresses Oil Site Violations In a determined effort to safeguard public health and air quality, the South Coast Air Quality Management District (South Coast AQMD) has recently taken enforcement action against three oil and gas facilities in Los Angeles. These actions were prompted by public complaints and confirmed violations of air quality regulations,...

Continue Reading
BAM UK & Ireland and LoadSpring Solutions Innovate Project Management

Updated Category News Views 199

BAM UK & Ireland and LoadSpring Solutions Innovate Project Management BAM UK & Ireland, a prominent name in the construction and engineering sector, has taken a bold step forward by partnering with LoadSpring Solutions. This collaboration aims to revolutionize project management through an innovative solution known as LoadSpring INSIGHTS™. This groundbreaking platform...

Continue Reading